Study: CGM Phenotypes Show Metabolic Differences in Older Adults With Type 2 Diabetes
Continuous glucose monitoring (CGM) is revealing metabolic patterns in older adults with Type 2 diabetes that standard HbA1c measurements often fail to capture, according to research published in the Journal of Diabetes in November 2026.
- Researchers identified four distinct glucose phenotypes by analyzing time above range (TAR) and mean amplitude of glycemic excursions (MAGE) in 2,491 older adults.
- Patients with high glucose exposure but low variability showed the strongest association with advanced cardiovascular-kidney-metabolic (CKM) syndrome.
- The findings suggest that tracking daily glucose fluctuations may provide greater insight into long-term organ health than average blood sugar levels alone.
The study, led by Hang Su and colleagues at the Shanghai Sixth People’s Hospital, examined clinical and biochemical data from 2,491 adults aged 60 and older. All participants had maintained stable glucose-lowering regimens for three months prior to the seven-day blinded CGM assessment.
European Medical Journal reported that the research aimed to characterize metabolic heterogeneity, as 65.0% of the study population met the American Heart Association criteria for advanced CKM syndrome, defined as Stages 3 or 4.
Glycemic Phenotypes and CKM Syndrome Associations
To categorize participants, researchers utilized an outcome-guided workflow that measured TAR—representing hyperglycemic burden—and MAGE, which captures glycemic variability. The population median values were established at 27.0% for TAR and 5.3 mmol/L for MAGE. Patients were subsequently sorted into four distinct phenotypes based on whether their CGM readings fell above or below these medians.

| Phenotype Category | Clinical Characteristic | CKM Syndrome Link |
|---|---|---|
| High TAR / High MAGE | Poorest glycemic control; highest HbA1c (9.1%) | High |
| High TAR / Low MAGE | Fasting hyperglycemia; lowest insulin sensitivity | Highest (73.3%) |
While the group with both high TAR and high MAGE exhibited the most significant hyperglycemic burden and the highest median HbA1c of 9.1%, they did not record the highest prevalence of advanced CKM syndrome.
That distinction belonged to the high TAR and low MAGE phenotype. Wisevoter.com said that this specific group demonstrated a pattern dominated by fasting hyperglycemia, alongside elevated triglyceride levels and the lowest insulin sensitivity among all four cohorts.
Clinical Implications for Diabetes Management
The data suggest that conventional glycaemic indicators may overlook specific metabolic risks in older populations. By applying the American Heart Association’s CKM framework to CGM data, the researchers identified markers that correlate more closely with cardiorenal morbidity than average glucose levels. This suggests a potential shift in how clinicians assess the progression of cardiovascular and kidney complications in patients with Type 2 diabetes.
The study was conducted by the Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and associated centers.
While these findings offer a new lens for viewing metabolic heterogeneity, the authors emphasize that the results are not yet a basis for altering established treatment protocols. Prospective studies remain necessary to confirm whether these specific CGM-derived phenotypes can reliably forecast future CKM progression or improve long-term cardiorenal outcomes.
Patients seeking to understand their own metabolic risk profiles should consult with board-certified endocrinologists or specialized diabetes educators. These clinicians can help determine if continuous glucose monitoring is appropriate for an individual’s specific health needs and how to interpret the resulting data within the context of broader cardiovascular and kidney health assessments.
The research conducted at Shanghai Sixth People’s Hospital benefits from the institution’s long-standing history, having been founded in 1904. As a large-scale tertiary general hospital, it operates with 2,366 beds across its Xuhui and Lingang campuses and manages an annual volume of over 5 million outpatient and emergency visits.
The hospital serves as the base for specialized research entities including the Shanghai Diabetes Institute and the Shanghai Key Laboratory of Diabetes. It is recognized as a national key clinical specialty center for endocrinology and metabolism, reflecting its extensive focus on the metabolic conditions examined in this study.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.